首页> 外文期刊>Biomedicine & preventive nutrition >Diallyl sulfide attenuates renal injury by altering the expressions of COX-2 and NF-κB during cisplatin-induced nephrotoxicity in male wistar rats
【24h】

Diallyl sulfide attenuates renal injury by altering the expressions of COX-2 and NF-κB during cisplatin-induced nephrotoxicity in male wistar rats

机译:二烯丙基硫醚通过改变顺铂诱导的雄性Wistar大鼠肾毒性期间COX-2和NF-κB的表达来减轻肾脏损伤

获取原文
获取原文并翻译 | 示例
       

摘要

Cis-diamminedichloroplatinum (II) (cisplatin) is an effective chemotherapeutic agent successfully used in the treatment of a wide range of tumours. However, its full clinical utility is limited due to some adverse effects. Diallyl sulfide (DAS) is a major flavour component of garlic. The present study is to evaluate nephroprotective effect of DAS on the cisplatin-induced nephrotoxicity. Male Wistar rats were divided into four groups of six each: Group I served as control rats; Group II received single intraperitoneal (i.p) injection of 7. mg/kg BW cisplatin. Group III received both cisplatin and DAS (100. mg/kg BW intraperitoneally); Group IV received DAS alone. Cisplatin administration significantly alters the levels of serum marker enzymes and renal tissue markers. DAS administration significantly reduced levels of serum marker enzymes and improved renal functions. Increase MDA level with a concomitant reduction in enzymic antioxidants and non-enzymic antioxidants were observed in cisplatin-induced group, which was reversed upon DAS treatment. Cisplatin-induced nephrotoxicity which is also supported by histopathological studies and elevated expressions of nuclear transcription factor-kappa B and Cyclooxygenase-2 in cisplatin-induced group, and it were attenuated upon DAS treatment. These results indicate that the antioxidant effect of DAS might contribute against cisplatin-induced nephrotoxicity in rats.
机译:顺二氨二氯铂(II)(顺铂)是一种有效的化学治疗剂,已成功地用于治疗多种肿瘤。但是,由于某些不良作用,其全部临床用途受到限制。二烯丙基硫醚(DAS)是大蒜的主要风味成分。本研究旨在评估DAS对顺铂诱导的肾毒性的保护作用。将雄性Wistar大鼠分成四组,每组六只:第一组为对照组;第二组为对照组。第二组接受腹膜内(i.p)单次注射7. mg / kg BW顺铂。第三组同时接受顺铂和DAS(腹膜内100. mg / kg体重)。第四组仅接受DAS。顺铂给药可显着改变血清标志物酶和肾组织标志物的水平。 DAS给药显着降低了血清标志物酶的水平并改善了肾功能。在顺铂诱导的组中观察到MDA水平升高,同时伴随着酶抗氧化剂和非酶抗氧化剂的减少,在DAS治疗后被逆转。组织病理学研究以及顺铂诱导组中核转录因子-κB和环氧合酶-2的表达升高也支持顺铂诱导的肾毒性,DAS处理后其减弱。这些结果表明,DAS的抗氧化作用可能对顺铂诱导的大鼠肾毒性有贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号